Dan Huh News Today

Vivodyne, a biotech company that accelerates AI-powered drug discovery by testing therapies on lab-grown human organs raises $38M

Philadelphia-based Vivodyne is growing human tissues in the lab to test potential new therapies before they go to clinical trials. The company was founded in 2021 at the University of Pennsylvania by Bioengineering PhD Andrei Georgescu and Associate Professor of Bioengineering Dan Huh. Vivodyne’s platform was originally developed at Penn in the BIOLines Laboratory. Vivodyne…

Khosla Ventures-backed Vivodyne is growing human tissues in the lab to test potential new therapies before they go to clinical trials.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Vivodyne, a biotech that discovers and develops more effective drugs by testing them on lab-grown human organs, today announced the close of $38 million in total seed financing, led by Khosla Ventures, with participation from Kairos Ventures, CS...

Rutgers University is teaming up with other top schools to launch a research center funded with a $5 million grant to find out how the placenta will support healthy pregnancies.

Rutgers University is teaming up with other top schools to launch a research center funded with a $5 million grant to find out how the placenta will support healthy pregnancies.

Rutgers University is teaming up with other top schools to launch a research center funded with a $5 million grant to find out how the placenta will support healthy pregnancies.

WASHINGTON--(BUSINESS WIRE)--Dr. Jane Goodall, DBE, UN Messenger of Peace and Founder of the Jane Goodall Institute, a conservation organization focused on environmental and humanitarian education, community-centered conservation, and primate care and research; and Vivodyne, an innovative biotechnology platform that...

Latest ‘organ-on-a-chip’ is a new way to study cancer-related muscle wasting Studying drug effects on human muscles just got easier thanks to a new “muscle-on-a-chip,” developed by a team of researchers from Penn’s School of Engineering and Applied Science and Inha University in Incheon, Korea. Bioengineering’s Dan Huh and colleagues have developed a number of organ-on-a-chip devices to simulate how human cells grow and perform in their natural environm...